The Department of Justice has accused a former Pfizer employee and his friend and business partner in participating in an insider-trading scheme based on confidential information about the results of clinical trials of a medicine used to treat COVID-19. Prosecutors in New York have accused 44-year-old Amit Dagar, of Hillsborough, New Jersey, of buying call…

“With the exception of the medical boards, all the authorities, or all the [organizations] in Brazil, they never wondered whether we saved lives or not. They just wanted to charge me as guilty.” Dr. Flavio Cadegiani is one of Brazil’s leading scientists, specializing in endocrinology and sports medicine. He has published 25 peer-reviewed papers on…

“With the exception of the medical boards, all the authorities, or all the [organizations] in Brazil, they never wondered whether we saved lives or not. They just wanted to charge me as guilty.” Dr. Flavio Cadegiani is one of Brazil’s leading scientists, specializing in endocrinology and sports medicine. He has published 25 peer-reviewed papers on…

“With the exception of the medical boards, all the authorities, or all the [organizations] in Brazil, they never wondered whether we saved lives or not. They just wanted to charge me as guilty.” Dr. Flavio Cadegiani is one of Brazil’s leading scientists, specializing in endocrinology and sports medicine. He has published 25 peer-reviewed papers on…

“With the exception of the medical boards, all the authorities, or all the [organizations] in Brazil, they never wondered whether we saved lives or not. They just wanted to charge me as guilty.” Dr. Flavio Cadegiani is one of Brazil’s leading scientists, specializing in endocrinology and sports medicine. He has published 25 peer-reviewed papers on…

The U.S. Food and Drug Administration (FDA) on May 25 fully approved Pfizer’s oral antiviral medication Paxlovid to treat mild to moderate COVID-19 in adults at risk of severe infections. This clears the way for the drugmaker to sell it at market rates once the U.S. government supplies dwindle. The FDA says that Paxlovid is…

An advisory committee from the U.S. Food and Drug Administration (FDA) has voted in favor of approving a new drug application for Pfizer’s COVID pill Paxlovid, even as potential drug interaction risks were highlighted during the committee meeting. Paxlovid is an oral antiviral pill that has been available for use in the United States since…

The National Institutes of Health (NIH) is conducting a multi-site clinical trial to evaluate Shionogi & Co.’s Xocova COVID-19 antiviral drug to determine its effectiveness in improving care for afflicted individuals. Xocova, also known as ensitrelvir fumaric acid or S-217622, was discovered by Osaka-based Shionogi and Hokkaido University in Sapporo, Japan. The trial will be…

Do you know when Paxlovid should be used to treat COVID-19? Are you aware of the reasons for the mixed results of its phase 2 and phase 3 clinical trial data versus its real-life studies? Do you know what the most significant concern about Paxlovid is for its future application in treating COVID-19? Reputed as…

As the world figures out how to coexist with COVID-19, the introduction of oral pills looks promising, in addition to the treatments of monoclonal antibodies and remdesivir. In this multiple series of articles, we will review three oral antivirals against COVID: Paxlovid developed by Pfizer, molnupiravir developed by Merck, and Azvudine developed by Genuine Biotech…